论文信息 - A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters - 字舞流文

A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters

K. To | Jian-Piao Cai | J. Chan | I. Hung | Zhiwei Chen | K. Yuen | H. Chu | Shuofeng Yuan | V. Poon | Jian-Dong Huang | C. Chan | K. Chik | Bao-Zhong Zhang | Li Liu | Wenjun Li | Ye-fan Hu | Hua-Rui Gong | Y. Dou | Kaiming Tang | C. Chan | Jingchu Hu | Xuechen Li | S. Badea | Xiao-lei Wang | Xuansheng Lin | Huarui Gong | Xiaolei Wang | Hin Chu